Theriva Biologics, Inc. (TOVX)
0.259
+0.01
(+4.39%)
USD |
NYAM |
Sep 03, 16:00
0.2467
-0.01
(-4.75%)
After-Hours: 19:54
Theriva Biologics Cash from Investing (Quarterly) : -0.003M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.003M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | -0.019M |
| June 30, 2025 | -0.016M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.001M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -0.056M |
| September 30, 2023 | -0.129M |
| June 30, 2023 | -0.009M |
| March 31, 2023 | -0.008M |
| December 31, 2022 | -0.091M |
| September 30, 2022 | -0.011M |
| June 30, 2022 | -0.014M |
| March 31, 2022 | -4.28M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.014M |
| December 31, 2020 | -0.005M |
| September 30, 2020 | -0.004M |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.007M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.003M |
| September 30, 2017 | -0.198M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.011M |
| December 31, 2016 | -0.37M |
| September 30, 2016 | -0.154M |
| June 30, 2016 | -0.001M |
| March 31, 2016 | -0.044M |
| December 31, 2015 | -0.044M |
| September 30, 2015 | -0.396M |
| June 30, 2015 | -0.043M |
| March 31, 2015 | -0.018M |
| December 31, 2014 | -0.005M |
| September 30, 2014 | -0.022M |
| June 30, 2014 | -0.017M |
| March 31, 2014 | -0.004M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Nkarta, Inc. | 21.15M |
| Unicycive Therapeutics, Inc. | -0.023M |
| OnKure Therapeutics, Inc. | -9.87M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.085M |
| Cash from Financing (Quarterly) | -0.014M |
| Free Cash Flow | -12.76M |
| Free Cash Flow Per Share (Quarterly) | -0.0673 |
| Free Cash Flow to Equity (Quarterly) | -2.948M |
| Free Cash Flow to Firm (Quarterly) | -3.088M |
| Free Cash Flow Yield | -149.0% |